Savara Pharmaceuticals
SVRA
#6301
Rank
S$0.80 B
Marketcap
$4.92
Share price
4.72%
Change (1 day)
4.64%
Change (1 year)

Savara Pharmaceuticals (SVRA) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$49.5 M

According to Savara Pharmaceuticals's latest financial reports the company's total liabilities are S$49.5 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Savara Pharmaceuticals - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$49.11 M14.5%
2022-12-31S$42.89 M-1.15%
2021-12-31S$43.39 M-1.68%
2020-12-31S$44.13 M-5.12%
2019-12-31S$46.51 M-22.73%
2018-12-31S$60.2 M11.64%
2017-12-31S$53.92 M-42.51%
2016-12-31S$93.79 M118.64%
2015-12-31S$42.89 M174.17%
2014-12-31S$15.64 M65.95%
2013-12-31S$9.42 M48.86%
2012-12-31S$6.33 M-3.68%
2011-12-31S$6.57 M183.38%
2010-12-31S$2.32 M-29.77%
2009-12-31S$3.3 M-50.99%
2008-12-31S$6.74 M33.58%
2007-12-31S$5.04 M32.48%
2006-12-31S$3.8 M-92.73%
2005-12-31S$52.36 M2534.46%
2004-12-31S$1.98 M617.55%
2003-12-31S$0.27 M-83.76%
2002-12-31S$1.7 M0.54%
2001-12-31S$1.69 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$15.86 M-67.96%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.76 B 1,440.77%๐Ÿ‡บ๐Ÿ‡ธ USA